Resources
Advanced Search
Start Free Trial
Talk With Sales
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
SurVac
Growth Score
80
CB Rank
3407542
Heat Score
50
Save
Actions
SurVac is focuses on the development of peptide based therapeutic cancer vaccines.
Acquired by
Merck
Founded
obfuscated
obfuscation
Private
Hellerup
,
Hovedstaden
,
Denmark
Biotechnology
Pharmaceutical
SurVac
Section: Technology
Actions